A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Remote Patient Monitoring Integrated with iVisit Telehealth Solution Launches

Remote Patient Monitoring Solution Launches

GenieMD, Inc. (“GenieMD”), GenieMD, provider of a HIPAA-compliant, cloud-based, mobile-first virtual care services platform, supporting several different care engagement modalities is announcing the official launch of their Remote Patient Monitoring solution – which is integrated with their globally deployed iVisit Telehealth solution.

“Now IPAs, ACOs, self-ensured employers, healthsystems and payers can adopt one platform to integrate with their delivery of care model,” said Thomas Foley, Chief Growth Officer, of GenieMD.

GenieMD, previously recognized as “The Most Innovative Telemedicine Solution Provider” now provides a complete end-to-end virtual care platform, inclusive of telehealth, remote patient monitoring and call triage services. Most often the iVisit virtual care services platform is white-labeled to advance the presence of our clients in their respective communities.  GenieMD further integrates computing platform, medical devices and medical carts, including the global logistics necessary to get remote patient monitoring kits to the targeted patient – resulting in a full end-to-end, one stop virtual care solution. This approach mitigates risks and further reduces costs to maximize utilization of limited financial resources.

“Given our experience with GenieMD* iVisit Telehealth platform and testing the robust features of the RPM services, there is very high confidence it will further enhance the delivery of care model across our community of care.” said, Dr. Juan Ramos, Chief Executive Officer, of Tu Salud Virtual.

“GenieMD’s iVisit virtual care solution portfolio facilitates innovative approach to delivery of care,” said Dr. Soheil Saadat, Chief Executive Officer, of GenieMD. “The iVisit portfolio coupled with the rich integration of medical devices allows our physicians to expand services to remotely monitoring patient across several chronic disease states.

*Based in San Francisco, CA, GenieMD, Inc. is an award-winning, global provider of telemedicine, remote patient monitoring and clinical call center triage solutions. GenieMD offers customized white-labeled telehealth solutions to hospitals, health networks, large group practices and commercial insurance carriers. Its enterprise clients are based throughout the United States as well as in Europe, Asia and South America. Maximizing the potential of cloud computing, big data, artificial intelligence and mobile technologies, GenieMD is transforming health care to provide the best and fastest care to patients when they need it most. GenieMD is Legitscript-approved, having met the highest standards for legality, safety and transparency. 

SourceGenieMD
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy